Wolf Reik | |
|---|---|
 Wolf Reik | |
| Nationality | German |
| Awards | EMBO Member[when?] FMedSci FRS |
| Scientific career | |
| Fields | epigenetics |
| Institutions | Babraham Institute University of Cambridge, Wellcome Trust Sanger Institute |
| Website | www |
Wolf Reik FRS[1] is a German-British molecular biologist and an honorary group leader at the Babraham Institute, honorary professor of Epigenetics at the University of Cambridge and associate faculty at the Wellcome Trust Sanger Institute.[2][3][4] He was announced as the director of Altos Labs Cambridge Institute when the company launched on 19 January 2022.[5]
- ^ Anon (2010). "Wolf Reik's FRS". royalsociety.org. London: Royal Society. Retrieved 2 January 2014.
- ^ "Wolf Reik's group". babraham.ac.uk. Babraham Institute.
- ^ "Wolf Reik at the Sanger". sanger.ac.uk. Wellcome Trust Sanger Institute.
- ^ Wolf Reik publications indexed by Google Scholar
- ^ Labs, Altos. "Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming". www.prnewswire.com (Press release). Retrieved 8 April 2022.
